AUROBINDO PHARMA LTD. - Clarifies on News item

With reference to the news article in The Economic Times, on July 22, 2015 captioned "Aurobindo Pharma Comes Under US FDA Lens", Aurobindo Pharma Ltd has Clarified to BSE as under:<BR><BR>"the said facility underwent a routine GMP inspection by USFDA and there are certain observations related to the systems and procedures. The Company is appropriately responding and this has no perceived impact on the operations and exports from the said facility."